Allied Blenders & Distillers Q2 FY27 Earnings Call: Record Volumes Cross 10 Million Cases, Rs. 1,600 Cr Capex To Lift Margins (ABDL)

Allied Blenders & Distillers Ltd held its Q2 FY27 earnings call on October 27, 2026. Here's a quick read of what management said — performance, strategy, and the outlook ahead.

Record Volumes, But Reported Margins Absorb Supply-Chain Shock

• Rs.1,152 crore Q2 FY 2026-2027 revenue — consolidated income from operations grew +15.8% YoY and +17.1% QoQ; quarterly volumes crossed 10 million cases for the first time vs 9 million in Q2 FY 2025-2026 (+11.1% YoY).
• Rs.143 crore reported EBITDA (12.4% margin) — +10% YoY, +19.2% QoQ, but margin down 66 bps YoY on brand investments; PAT at Rs.69 crore (+9.7% YoY, +52% QoQ).
• ~Rs.29 crore Q2 / Rs.53 crore H1 FY 2026-2027 hit from global supply chain disruptions; like-to-like Q2 was materially stronger: gross margin 47.9% (+342 bps YoY), EBITDA Rs.172 crore (+32.3% YoY), PAT Rs.91 crore (+44.3% YoY).
• H1 FY 2026-2027 revenue of Rs.2,135 crore (+10.9% YoY) — reported PAT of Rs.114 crore was below Rs.119 crore in H1 FY 2025-2026, though like-to-like PAT of Rs.154 crore grew +29.8% YoY.
• Rs.269 crore H1 FY 2026-2027 operating cash flow — up from Rs.147 crore in H1 FY 2025-2026; net debt Rs.1,273 crore (Sep 2026) vs Rs.981 crore (Mar 2026) on Rs.351 crore H1 capex.
• India Ratings and Research upgraded ABD by two notches to IND A+/AA- with stable outlook.

Iconic White Leads; Mass Premium Revival Outpaces Prestige Volumes

• Iconic White at 3.2 million cases in Q2 FY 2026-2027 (+20.6% YoY from 2.6 million); H1 volumes of 6.2 million cases (+26.8% YoY) with >1 million cases/month every month of FY 2026-2027; MD Amar Sinha termed the flat sequential trend vs Q1's 3.1 million "just an aberration" and denied regional-brand cannibalization.
• Mass premium & others NSV of Rs.468 crore in Q2 FY 2026-2027 (+15.9% YoY) on +15.5% volumes; Andhra Pradesh brandy rollout reached near double-digit share of India's largest brandy market; Officer's Choice retains mass premium whiskey leadership (40% share, 45% gross margin per MD) and is India's number one exported whiskey brand.
• Prestige & above sales of Rs.605 crore in Q2 FY 2026-2027 (+13.4% YoY) but volumes grew only +6.1%; contributed 56.4% of value sales (vs 56.9% YoY) and 45% of volumes (vs 47.1%); management attributed the volume gap to mass premium's improved saliency, not P&A weakness. Analyst cited a ~20% P&A ex-Iconic decline in Q2 FY 2026-2027.
• Power brands show early revival — Officer's Choice Blue, Sterling Reserve B7 and Officer's Choice all grew for the first time in Q2 FY 2026-2027; OC Blue's degrowth was arrested after its September 2026 premium packaging refresh (UP, Maharashtra, Haryana, West Bengal). Management attributed earlier weakness to the pre-IPO period (IPO July 2024) when brands were not nurtured.
• ABD Maestro scaling from a small base — FY 2025-2026 turnover of Rs.20 crore, guided to Rs.80 crore in FY 2026-2027 (a Rs.40 crore FY26 figure was also stated in the call); 10-brand portfolio in ~80% of addressable Indian markets and 7 international countries, with 35+ global awards since FY 2025-2026 inception.
• New launches — premium whiskey "Indian Edit" launched September 2026 across seven states at a Rs.1,550 price point in Maharashtra; management said it will attract consumers from competing super-premium and premium brands rather than trade up from Sterling Reserve; a vodka launch is planned before FY 2026-2027 ends.

Rs.1,600 Cr Program Targets 450 bps of Margin Accretion by FY 2028-2029

• 250 bps of FY 2026-2027 margin lost to West Asia crisis inflation — management said FY27 EBITDA margin would have been 15% absent the crisis; inflation has run ~6 months and is expected to run another ~3 months (into early Q4 FY 2026-2027). MD Amar Sinha said he is "only hoping" Q4 FY 2026-2027 will be much better; pressure remains for now.
• Backward integration guided to deliver ~300 bps EBITDA margin benefit by FY 2027-2028 and a further 150 bps in FY 2028-2029 (cumulative 450 bps); management expects the program to be completed on time and EBITDA-accretive by FY 2028-2029.
• Rs.1,600 crore capex program — only 25% spent till FY 2025-2026, ~Rs.300 crore spent in FY 2026-2027 to date, balance over the next 3 years; management does not envisage capex beyond this program other than routine maintenance capex of Rs.75-100 crore per annum (FY 2026-2027 onwards) across 40 plants.
• UP investments progressing — Moradabad bottling commenced October 2026 at 6 million cases/year (Rs.27/case franchise-fee savings), with expansion to 13 million cases/year targeted by Q4 FY 2026-2027 (~Rs.202 crore), plus a 66 million bulk liter dual-mode distillery (~Rs.293.5 crore) announced August 2026 under a >Rs.600 crore UP investment.
• Telangana captive malt distillery (Rangapur) commissioned October 2026 — ~Rs.75 crore, 4 million bulk liters capacity; own malt usable for blending within 12-15 months (during FY 2027-2028), with fully matured own malt ready after 3 years (~FY 2029-2030); Aurangabad bottling expected operational within a couple of months (FY 2026-2027) and ENA expansion on track for H1 FY 2027-2028.
• Leverage marginally above framework — net debt/EBITDA at 2.2x and net debt/equity at 0.8x vs the stated <2x/<0.75x framework; management expects metrics within framework on a full FY 2026-2027 basis.

Asset-Light Exports Scale; Tamil Nadu and CSD Channels Open Up

• Exports expanded from 36 to 42 countries in FY 2026-2027 — management targets 50 countries within the next 12 months (by FY 2027-2028); August 2026 saw the first overseas local production arrangement in Malaysia via asset-light co-bottling, which the CFO clarified is a contract bottling arrangement with surplus recognized in other income, not a royalty model.
• Entered the CSD and paramilitary channel with 4 brands in FY 2026-2027 — management flagged defense/paramilitary as a large untapped growth opportunity.
• Retail distribution spans 100,000+ outlets with ABD presence in 90% (as of Q2 FY 2026-2027); management noted liquor distribution channels are structurally restricted with no scope to add new ones; ~20,000 outlets are premium on-premise key accounts.
• Tamil Nadu liberalization anticipated — MD Amar Sinha said management anticipates the market opening (new brands already being registered) in a state exceeding 50 lakh cases/month, and expects value and margin accretion industry-wide across alcobev companies, drawing a parallel to UP's evolution.
• Karnataka remains a small presence — ABD sells 40,000-50,000 cases/month in a ~65 million case p.a. market where premium is only 10-12%; Iconic has grown over the last two months but management said real impact will be gauged over the next six months — market evolution "yet to be seen".

Bulk Scotch Duty Uncertainty Dilutes FTA Benefit; Pricing in Government Hands

• Government authorities have raised uncertainties on bulk scotch import duty under applicable HSN codes, diluting the India-UK FTA benefit; industry body CIABC has taken the matter up with government for early resolution.
• India-UK FTA benefit of ~70 bps expected in FY 2026-2027 — both the Indian and UK governments are in talks, the company has made a representation, and management is optimistic of resolution over the next one month (Q3 FY 2026-2027); stocks will last till early December 2026 (Q3 FY 2026-2027) by which time management hopes the issue is resolved.
• Liquor prices are government-controlled — management noted prices cannot be raised at will, though governments have granted increases in most states over the last 3-4 years; a Telangana increase is the most imminent ("on the cards"), and the company is pursuing increases in many other states through the association of alcoholic beverage companies.
• Management is watchful of inflation, geopolitical developments and input cost volatility; value engineering is underway on packaging materials; Telangana policy, anticipated price revisions and improving sentiment on clearance of outstanding Telangana dues were seen as supportive.
• Competitive intensity flagged by analysts — McDowell's relaunch with refreshed liquid and packaging and Imperial Blue's aggression; management noted ~55% of India's 440 million-case market sits below the premium segment and that ABD grew 2.5% in Q1 FY 2026-2027 while the industry declined.

Mid-Teens Top Line Intact; Transformation Roadmap Runs Through FY 2028-2029

• FY 2026-2027 top line expected to grow in line with stated mid-teens guidance; FY 2026-2027 EBITDA margin expected broadly in line with FY 2025-2026, with management hoping to match FY26's margin by the close of FY27 despite the crisis and "no looking back" from FY 2027-2028 onwards.
• H2 FY 2026-2027 guided to mid-teens to high-teens-plus volume growth, aided by seasonality, operating leverage, a better premium mix from new launches (Indian Edit; a likely vodka launch), and Officer's Choice packaging refurbishment by Q4 FY 2026-2027; ~100 bps of gross margin accretion expected in H2 FY 2026-2027.
• Iconic White targeted at close to 14 million cases in FY 2026-2027 (>25% growth vs 10.7 million in FY 2025-2026), with an internal goal of 20 million cases within the next two years (through FY 2028-2029); an analyst noted ~30% growth is needed to hit the FY 2026-2027 target; a 40:60 season ratio implies bulk of volumes in H2 FY 2026-2027.
• Internal ambition to cross 50 million cases by FY 2028-2029 (vs 36 million in FY 2025-2026), contingent on profitable growth; management plans to scale up Officer's Choice Blue and Sterling Reserve B7 (together >5.5 million cases) over the next two years through FY 2028-2029.
• P&A saliency target of 50%+ volumes and 60%+ value within the next one year (FY 2027-2028); Sterling Reserve B7 new packaging rollout targeted in Q4 FY 2026-2027; Officer's Choice complete brand reset with new packaging and marketing communication by Q3 FY 2026-2027; white-space opportunities include deluxe vodka.
• Transformation journey over the next two years (through FY 2028-2029) — MD Amar Sinha (6 months at ABD, ~4 as MD) is focused on profitable top-line growth and capex execution, pivoting ABD to value-led, premiumization-driven growth.